Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Tissue Collection Study in Patients With Renal Clear Cell Carcinoma Who Respond to Immune Checkpoint Inhibitors to Identify Targets of Tumor-Reactive T Cells

NCT04680416 is registered in ClinicalTrials.gov with TScan Therapeutics, Inc. as lead sponsor.

NCT NCT04680416
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04680416 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Tissue Collection Study in Patients With Renal Clear Cell Carcinoma Who Respond to Immune Checkpoint Inhibitors to Identify Targets of Tumor-Reactive T Cells
Lead sponsor
TScan Therapeutics, Inc.
Phase
Observational
Overall status
Withdrawn
Start date
December 17, 2020
Completion date
August 4, 2021
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

renal clear cell carcinoma